Médica Sur S.A.B. de C.V
Médica Sur, S.A.B. de C.V. operates as a healthcare hospital in Mexico. The company offers angiology, vascular, and endovascular surgery; bariatric surgery; cancer; cardiology; checkup and preventive medicine; children; dental; emergency; endocrinology; gastroenterology, hepatology, and endoscopy; general surgery; geriatric; and gynecology and obstetrics services. It also provides specialized sur… Read more
Médica Sur S.A.B. de C.V (MEDICAB) - Net Assets
Latest net assets as of December 2025: MX$2.52 Billion MXN
Based on the latest financial reports, Médica Sur S.A.B. de C.V (MEDICAB) has net assets worth MX$2.52 Billion MXN as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (MX$4.78 Billion) and total liabilities (MX$2.25 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | MX$2.52 Billion |
| % of Total Assets | 52.81% |
| Annual Growth Rate | 6.75% |
| 5-Year Change | -48.67% |
| 10-Year Change | -23.73% |
| Growth Volatility | 14.26 |
Médica Sur S.A.B. de C.V - Net Assets Trend (2000–2025)
This chart illustrates how Médica Sur S.A.B. de C.V's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Médica Sur S.A.B. de C.V (2000–2025)
The table below shows the annual net assets of Médica Sur S.A.B. de C.V from 2000 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | MX$2.52 Billion | +7.62% |
| 2024-12-31 | MX$2.34 Billion | +15.06% |
| 2023-12-31 | MX$2.04 Billion | -19.23% |
| 2022-12-31 | MX$2.52 Billion | -48.67% |
| 2021-12-31 | MX$4.91 Billion | +22.59% |
| 2020-12-31 | MX$4.01 Billion | +8.86% |
| 2019-12-31 | MX$3.68 Billion | +3.97% |
| 2018-12-31 | MX$3.54 Billion | +2.75% |
| 2017-12-31 | MX$3.45 Billion | +4.21% |
| 2016-12-31 | MX$3.31 Billion | +1.97% |
| 2015-12-31 | MX$3.24 Billion | +4.38% |
| 2014-12-31 | MX$3.11 Billion | +12.68% |
| 2013-12-31 | MX$2.76 Billion | +6.56% |
| 2012-12-31 | MX$2.59 Billion | +19.10% |
| 2011-12-31 | MX$2.17 Billion | +15.63% |
| 2010-12-31 | MX$1.88 Billion | +9.52% |
| 2009-12-31 | MX$1.72 Billion | +11.27% |
| 2008-12-31 | MX$1.54 Billion | +9.19% |
| 2007-12-31 | MX$1.41 Billion | +16.48% |
| 2006-12-31 | MX$1.21 Billion | +17.79% |
| 2005-12-31 | MX$1.03 Billion | +14.27% |
| 2004-12-31 | MX$900.86 Million | +16.62% |
| 2003-12-31 | MX$772.45 Million | +17.09% |
| 2002-12-31 | MX$659.71 Million | +20.84% |
| 2001-12-31 | MX$545.95 Million | +10.81% |
| 2000-12-31 | MX$492.70 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Médica Sur S.A.B. de C.V's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 6629.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | MX$1.96 Billion | 77.91% |
| Other Components | MX$556.97 Million | 22.09% |
| Total Equity | MX$2.52 Billion | 100.00% |
Médica Sur S.A.B. de C.V Competitors by Market Cap
The table below lists competitors of Médica Sur S.A.B. de C.V ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Dream Unlimited Corp
PINK:DRUNF
|
$272.77 Million |
|
Jiangsu Phoenix Property Investment Co Ltd
SHG:600716
|
$272.79 Million |
|
Eventbrite Inc
F:EB4
|
$272.86 Million |
|
Shaanxi Kanghui Pharm Co Ltd
SHG:603139
|
$272.90 Million |
|
Apex International Co Ltd
TW:4927
|
$272.63 Million |
|
Yantai Zhenghai Bio-Tech Co Ltd
SHE:300653
|
$272.61 Million |
|
Shanghai Challenge Textile Co Ltd
SHE:002486
|
$272.60 Million |
|
Tae Kwang Corporation
KQ:023160
|
$272.58 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Médica Sur S.A.B. de C.V's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 2,343,039,000 to 2,521,726,000, a change of 178,687,000 (7.6%).
- Net income of 540,249,000 contributed positively to equity growth.
- Dividend payments of 147,024,000 reduced retained earnings.
- Share repurchases of 217,074,000 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | MX$540.25 Million | +21.42% |
| Dividends Paid | MX$147.02 Million | -5.83% |
| Share Repurchases | MX$217.07 Million | -8.61% |
| Other Changes | MX$2.54 Million | +0.1% |
| Total Change | MX$- | 7.63% |
Book Value vs Market Value Analysis
This analysis compares Médica Sur S.A.B. de C.V's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.21x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | MX$27.95 | MX$61.05 | x |
| 2018-12-31 | MX$28.72 | MX$61.05 | x |
| 2019-12-31 | MX$29.87 | MX$61.05 | x |
| 2020-12-31 | MX$32.51 | MX$61.05 | x |
| 2021-12-31 | MX$39.85 | MX$61.05 | x |
| 2022-12-31 | MX$23.36 | MX$61.05 | x |
| 2023-12-31 | MX$21.27 | MX$61.05 | x |
| 2024-12-31 | MX$24.47 | MX$61.05 | x |
| 2025-12-31 | MX$27.61 | MX$61.05 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Médica Sur S.A.B. de C.V utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 21.42%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 11.28%
- • Asset Turnover: 1.00x
- • Equity Multiplier: 1.89x
- Recent ROE (21.42%) is above the historical average (14.42%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | 11.06% | 6.18% | 0.61x | 2.92x | MX$3.68 Million |
| 2001 | 13.36% | 10.57% | 0.70x | 1.81x | MX$18.36 Million |
| 2002 | 15.83% | 13.24% | 0.73x | 1.63x | MX$38.47 Million |
| 2003 | 14.54% | 13.24% | 0.71x | 1.55x | MX$35.08 Million |
| 2004 | 14.64% | 14.02% | 0.68x | 1.54x | MX$41.75 Million |
| 2005 | 14.04% | 13.66% | 0.68x | 1.51x | MX$41.53 Million |
| 2006 | 16.02% | 15.86% | 0.72x | 1.40x | MX$72.97 Million |
| 2007 | 15.32% | 15.63% | 0.70x | 1.41x | MX$75.07 Million |
| 2008 | 12.56% | 12.55% | 0.63x | 1.58x | MX$39.49 Million |
| 2009 | 13.80% | 13.37% | 0.63x | 1.64x | MX$65.21 Million |
| 2010 | 12.31% | 12.82% | 0.64x | 1.49x | MX$43.39 Million |
| 2011 | 10.31% | 11.79% | 0.63x | 1.39x | MX$6.79 Million |
| 2012 | 11.61% | 14.38% | 0.62x | 1.30x | MX$41.78 Million |
| 2013 | 13.77% | 16.83% | 0.68x | 1.21x | MX$104.05 Million |
| 2014 | 11.24% | 15.23% | 0.63x | 1.17x | MX$38.40 Million |
| 2015 | 7.43% | 10.58% | 0.60x | 1.16x | MX$-83.26 Million |
| 2016 | 4.32% | 5.51% | 0.47x | 1.65x | MX$-187.69 Million |
| 2017 | 6.73% | 6.76% | 0.61x | 1.63x | MX$-112.79 Million |
| 2018 | 4.78% | 4.69% | 0.66x | 1.54x | MX$-184.78 Million |
| 2019 | 3.82% | 3.80% | 0.63x | 1.59x | MX$-227.60 Million |
| 2020 | 13.94% | 12.51% | 0.71x | 1.57x | MX$158.04 Million |
| 2021 | 23.50% | 29.56% | 0.56x | 1.42x | MX$663.18 Million |
| 2022 | 37.67% | 24.56% | 0.85x | 1.82x | MX$697.67 Million |
| 2023 | 31.18% | 15.38% | 1.00x | 2.03x | MX$431.36 Million |
| 2024 | 19.70% | 10.48% | 1.00x | 1.88x | MX$227.21 Million |
| 2025 | 21.42% | 11.28% | 1.00x | 1.89x | MX$288.08 Million |
Industry Comparison
This section compares Médica Sur S.A.B. de C.V's net assets metrics with peer companies in the Medical Care Facilities industry.
No peer company data available for comparison.